
Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained
3/31/2025
0:00
27:29
How do the eligibility criteria for the monarchE and NATALEE clinical trials compare?
Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002403?ecd=bdc_podcast_libsyn_mscpedu
More episodes from "Keeping Current CME"
Don't miss an episode of “Keeping Current CME” and subscribe to it in the GetPodcast app.